Amanda L. Kong

Also affiliated with Aetion (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy”.

Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07038-3

N/A

0.545DataRank · unranked

10 citations

Julie M. Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind +16 more

Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast

Journal of Surgical Research(2021)10.1016/j.jss.2021.02.020

N/A

0DataRank · unranked

10 citations

Amanda L. Kong, Julia Frebault, Shane Huang, Chiang‐Ching Huang, Chandler S. Cortina +1 more

Assessing the Effectiveness of Tobacco 21 Laws to Reduce Underage Access to Tobacco: Protocol for a Repeated Multi-Site Study

Preprints.org(2022)10.20944/preprints202206.0091.v1

N/A

0DataRank · unranked

1 citations

Amanda L. Kong, Christopher Ackerman, Shawna V. Hudson, Cristine D. Delnevo, Mary Hrywna

Chemotherapy, Microvascular Function, and Angiogenesis ‐ a Longitudinal Study

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r5465

N/A

0DataRank · unranked

0 citations

Shelby Hader, Janée D. Terwoord, Daniela N. Didier, Amanda L. Kong, Andreas Beyer +1 more

ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology

Annals of Surgical Oncology(2022)10.1245/s10434-022-12137-4

N/A

0DataRank · unranked

0 citations

Julie M. Jorns, Amanda L. Kong, Chandler S. Cortina, Enrique Ortega Martínez

Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy

Research Square(2023)10.21203/rs.3.rs-2777910/v1

N/A

0DataRank · unranked

2 citations

Julie M. Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind +16 more

The Use of Sentinel Lymph Node Biopsy in Patients Undergoing Mastectomy for DCIS

Clinical Breast Cancer(2024)10.1016/j.clbc.2024.07.003

N/A

0DataRank · unranked

8 citations

Chandler S. Cortina, Mohammed Aldakkak, Chiang‐Ching Huang, Amanda L. Kong, Morgan K. Johnson

Examining the false-negative rate of a negative axillary node ultrasound-guided core needle biopsy in breast cancer patients undergoing upfront surgery

The American Journal of Surgery(2024)10.1016/j.amjsurg.2024.116047

N/A

0DataRank · unranked

3 citations

Sarah Zeien, Kaleen Puccetti, Julie M. Jorns, Amanda L. Kong, Solomon Cherian +2 more

Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?

Annals of Surgical Oncology(2024)10.1245/s10434-024-14914-9

N/A

0DataRank · unranked

10 citations

Jan Irene Lloren, Christine Rogers, Morgan K. Johnson, Adrienne N. Cobb, Chiang‐Ching Huang +4 more

A systematic review of sebaceous carcinoma of the breast from 2000–2023: A rare entity with high recurrence rates

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100074

N/A

0DataRank · unranked

1 citations

Colleen P. Flanagan, Amanda L. Kong, Chandler S. Cortina, Lauren N Cohen

Adjuvant breast radiation therapy practice patterns in the United States from 2012–2017

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100093

N/A

0DataRank · unranked

1 citations

Chandler S. Cortina, Julie A. Kijak, Julie A. Bradley, Mohammed Aldakkak, Carmen Bergom +2 more

Should surgeons reconsider the role of intraoperative sentinel lymph node evaluation for premenopausal breast cancer patients in the era of RxPONDER?

The American Journal of Surgery(2024)10.1016/j.amjsurg.2024.02.027

N/A

0DataRank · unranked

1 citations

Amanda L. Kong, Chandler S. Cortina

Are there differences in overall survival among older breast cancer patients by race and ethnicity?

Surgery(2024)10.1016/j.surg.2024.06.085

N/A

0DataRank · unranked

0 citations

Christine Rogers, Xiaowei Dong, Chiang‐Ching Huang, Amanda L. Kong, Chandler S. Cortina +1 more

National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07750-2

N/A

0DataRank · unranked

5 citations

Christine C Rogers, Jan Irene Lloren, Sailaja Kamaraju, Lubna N. Chaudhary, Chiang‐Ching Huang +6 more

Characterization of anticancer therapy–induced microvascular dysfunction in patients with breast cancer supports targeted intervention

JCI Insight(2025)10.1172/jci.insight.194316

N/A

0DataRank · unranked

5 citations

Laura E. Norwood Toro, Shelby Hader, Stephen T. Hammond, Joseph C. Hockenberry, Jasmine M. Linn +9 more

Postmastectomy breast reconstruction in women aged 70 and older: An analysis of the National Cancer Database (NCDB)

Surgery(2021)10.1016/j.surg.2021.03.033

N/A

0DataRank · unranked

15 citations

Carmen Bergom, Julie Kijack, Abigail Thorgerson, Chiang‐Ching Huang, Amanda L. Kong +1 more

Does neoadjuvant systemic therapy in clinical T1–2 N0 human epidermal growth factor receptor 2–positive breast cancer increase the extent of axillary surgery?

Surgery(2025)10.1016/j.surg.2025.109907

N/A

0DataRank · unranked

0 citations

Lauren N. Cohen, Jan Irene Lloren, Chiang‐Ching Huang, Adrienne N. Cobb, Amanda L. Kong +4 more